Listen to the article
0:00
Les candidats des 15 et 22 mars ne cessent d’être interpellés sur l’accès aux soins, qui apparaît comme l’une des préoccupations centrales des habitants. Mais si les initiatives se sont multipliées pour attirer des médecins, de nombreuses limites demeurent.
14 commentaires
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.